FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI), a biotechnology company specializing in the development and commercialization of innovative bioactive products to promote the healing of musculoskeletal injuries and diseases, today announced the results of its 2011 Annual Meeting of Stockholders that took place on June 14, 2011 at the Company’s headquarters. The Company’s shareholders voted in favor of all proposals identified in the Proxy Statement.
